Realizing the untapped power of phages
We are an unique research-based company pushing the boundaries of what phage can do for human health and industry
_edited.jpg)
Next Generation Phage Technologies
At Inphasol, we envision phage applications that extend well beyond their use as antimicrobials and use data-driven phage engineering to harness the power of phage biology for innovative solutions.
Technology
About us
Founded in 2022 by members of Texas A&M's Center for Phage Technology (CPT), Inphasol's mission is to translate our wealth of genetic engineering and phage expertise to therapeutic and commercial applications. Collectively, our team has more than 140 years of phage research experience, and our core technology "PIPER" builds upon decades of research performed at the CPT. The adaptability and modular nature of our platform makes it broadly applicable to therapeutic, commercial, and environmental applications. Our initial product pipeline focuses on microbiome based treatments.
The Founders
Mei Liu, Ph.D
Founding CEO
Program Director, Center for Phage Technology, Texas A&M
22 years phage experience
6 years in phage start-up
Jason J. Gill, Ph.D
Founding CSO
Associate Professor
Co-Director, Center for Phage Technology, Texas A&M
28 years phage experience
Advisory board ADM
Consultant Jenssen, Merck, FDA, NIH
Justin Boeckman, Ph.D
Founding CTO
Research Scientist, Center for Phage Technology, Texas A&M
8 years phage experience
Ryland F. Young III, Ph.D
Founding Advisor
Distinguished and Regents Professor
Founding Director for Center for Phage Technology, Texas A&M
46 years phage experience
Advisory Board GangaGen
Consultant for multiple biotech companies and federal agencies
Carlos Gonzalez, Ph.D
Founding Advisor
Professor,
Center for Phage Technology, Texas A&M
38 years experience in phage research, 7 years of biotech experience (MicroLife Genetics / Unilever), PI of commercial phage product for Pierce’s Disease
Partnerships
Our business model and refinement of our PIPER technology thrives on partnerships. Should you have an academic research interest in our technology or a commercial interest in expressing a difficult protein or large multimeric protein complex, please contact us today, Whether the cargo be therapeutic or industrial in nature, we would be happy to discuss how the flexibility and power of our PIPER microbial cell factories can solve your protein expression and/or delivery bottlenecks.
Contact Us
For partnership opportunities or general inquiries, please email us at info@inphasol.com. Along with your inquiry, please be sure to also include your name and your associated company/institution.
